Jay Moyes
Net worth: 430 492 $ as of 2026-05-30
Net worth: 430 492 $ as of 2026-05-30
Mr. Jay M.
Moyes is an Independent Director at SINTX Technologies, Inc., a Lead Independent Director at Puma Biotechnology, Inc., an Independent Director at BioCardia, Inc., a Managing Member at Drayton Investments LLC and a Member at Utah Association of Certified Public Accountants.
He is on the Board of Directors at SINTX Technologies, Inc., Puma Biotechnology, Inc. and BioCardia, Inc. Mr. Moyes was previously employed as a Chief Financial Officer & Treasurer by Sera Prognostics, Inc., an Independent Director by Predictive Technology Group, Inc., an Independent Director by Achieve Life Sciences, Inc., an Independent Director by Integrated Diagnostics, Inc., a Chief Financial Officer by XDx, Inc., an Independent Non-Executive Director by Osiris Therapeutics, Inc., a Trustee by Utah Life Science Association, a Chief Financial Officer by Myriad Genetics, Inc., a Chief Financial Officer & Vice President-Finance by Genmarks, Inc., and a Senior Manager by KPMG LLP.
He also served on the board at BioCardia, Inc. /Old/.
He received his undergraduate degree from Weber State University and an MBA from the University of Utah.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-11 | 58,322 ( 0.11% ) | 418 169 $ | 2026-05-30 | |
| 2026-02-22 | 4,000 ( 0.09% ) | 8 960 $ | 2026-05-30 | |
BIOCARDIA, INC. 0.03% | 2025-12-07 | 3,616 ( 0.03% ) | 3 363 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 2012-04-26 |
| BIOCARDIA, INC. | Director/Board Member | 2010-12-31 |
| SINTX TECHNOLOGIES, INC. | Director/Board Member | 2025-04-02 |
Drayton Investments LLC | Corporate Officer/Principal | - |
Utah Association of Certified Public Accountants | Corporate Officer/Principal | 2010-06-02 |
| Companies | Position | End |
|---|---|---|
| SERA PROGNOSTICS, INC. | Director of Finance/CFO | 2023-06-06 |
| ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 2023-06-06 |
| PREDICTIVE TECHNOLOGY GROUP, INC. | Director/Board Member | 2019-11-30 |
| OSIRIS THERAPEUTICS, INC. | Director/Board Member | 2017-12-12 |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 18 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Genmarks, Inc.
Genmarks, Inc. Engineering & ConstructionIndustrial Services Part of Nutrien Ltd., Genmarks, Inc. is a company based in Greeley, CO. | Industrial Services |
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
SINTX Technologies, Inc.
SINTX Technologies, Inc. Medical SpecialtiesHealth Technology Develops and designs spinal & reconstructive orthopedic devices | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a molecular diagnostics company | Health Services |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weber State University
Weber State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Utah Life Science Association
Utah Life Science Association Miscellaneous Commercial ServicesCommercial Services Develops partnerships in the life science industries | Commercial Services |
Utah Association of Certified Public Accountants | |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
Predictive Technology Group, Inc.
Predictive Technology Group, Inc. Medical SpecialtiesHealth Technology Develops technologies involved in novel molecular diagnostic and therapeutic products in healthcare | Health Technology |
Sera Prognostics, Inc.
Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Puma Biotechnology, Inc.
Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Drayton Investments LLC | |
BioCardia, Inc.
BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Select your edition
All financial news and data tailored to specific country editions